FDA Approved: IBANDRONATE SODIUM — Original Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved an Abbreviated New Drug Application for ibandronate sodium from Mylan Institutional LLC, granting a generic version of ibandronate sodium for postm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• IBANDRONATE SODIUM (ibandronate sodium)

Snippet

ORIG AP for IBANDRONATE SODIUM (IBANDRONATE SODIUM)